Search results for "Core"

showing 10 items of 1999 documents

About entangled networks of worm-like micelles: a rejected hypothesis

1996

We report new results from small-angle neutron scattering on d(1 2)-cyclohexane/lecithin/water micellar solutions performed as a function of the water content (w(o)), temperature (T) and dispersed phase volume fraction (phi). The data from dilute samples are interpretable in terms of the existence of giant cylindrical reverse micelles and are well fit with a core-shell model (that provides the micelle structure and dimensions) with values of 28 and 45 Angstrom for the inner core and the outer shell radii, almost independent on temperature and concentration. Such a result could appear consistent with the current idea that worm-like micelles are living polymers. On the contrary, the appearanc…

ORGANOGELSPolymers and PlasticsSANSChemistryInner coreForm factor (quantum field theory)Concentration effectThermodynamicsMineralogyliving polymersNeutron scatteringgelsSmall-angle neutron scatteringMicelleLIGHT-SCATTERINGCondensed Matter::Soft Condensed MatterColloid and Surface ChemistryMICROEMULSIONSMicellar solutionsMaterials Chemistryreverse micellesPhysical and Theoretical ChemistryStructure factorLECITHIN REVERSE MICELLESColloid and Polymer Science
researchProduct

Merits and differences between single-site robotic and laparoscopic cholecystectomy: What is unfair? Commentary on "Propensity score-matching analysi…

2020

Obese patientmedicine.medical_specialtymedicine.medical_treatmentMEDLINEBiliary leakageSingle-site laparoscopicRobotic Surgical ProceduresSingle sitemedicineCholecystectomyPropensity ScoreLaparoscopic cholecystectomyRetrospective StudiesOutcomebusiness.industryGeneral surgeryRobotic Surgical ProceduresRetrospective cohort studyGeneral MedicineSingle incision laparoscopicCholecystectomy LaparoscopicSingle-site robotic cholecystectomyPropensity score matchingSurgeryCholecystectomybusinessInternational Journal of Surgery
researchProduct

UPC++ for bioinformatics: A case study using genome-wide association studies

2014

Modern genotyping technologies are able to obtain up to a few million genetic markers (such as SNPs) of an individual within a few minutes of time. Detecting epistasis, such as SNP-SNP interactions, in Genome-Wide Association Studies is an important but time-consuming operation since statistical computations have to be performed for each pair of measured markers. Therefore, a variety of HPC architectures have been used to accelerate these studies. In this work we present a parallel approach for multi-core clusters, which is implemented with UPC++ and takes advantage of the features available in the Partitioned Global Address Space and Object Oriented Programming models. Our solution is base…

Object-oriented programmingComputingMethodologies_PATTERNRECOGNITIONComputer scienceComputationSingle-coreGenome-wide association studyPartitioned global address spaceParallel computingBioinformaticsSupercomputer2014 IEEE International Conference on Cluster Computing (CLUSTER)
researchProduct

Analysis of the spawning stock-recruitment relationship of vendace (Coregonus albula (L.)) with evaluation of alternative models, additional variable…

2004

–  Spawning biomass and recruitment data for vendace from a central Finnish lake were analysed by fitting various recruitment models and comparing the fits statistically. The compensatory models of Ricker, Cushing and Beverton & Holt fitted the data better than the H0 hypothesis of constant proportionality, but model and parameter uncertainties were high. Additional variables were included in an attempt to reduce uncertainties. Heavy wind forcing during the first month after hatching of larvae reduced the recruitment success. For the Ricker and the Cushing models, recruitment seemed to be also negatively associated with the density of the previous year-class. The r2 increased considerably w…

Observational errorEcologybiologyEcologyModel parametersAquatic Sciencebiology.organism_classificationDensity dependenceNegatively associatedCoregonus albulaEcology Evolution Behavior and SystematicsStock (geology)Wind forcingMathematicsEcology of Freshwater Fish
researchProduct

A Model of Multiproduct Price Competition

1997

Abstract We provide a simple model of price competition in a multiproduct oligopoly market. The products are of general nature. We find that a pure strategy equilibrium exists and every equilibrium consumption maximizes the total social surplus. Consumers are characterized by a set function which determines their willingness to pay for every subset of products. If this function is convex, the set of equilibrium prices coincides with the core of a cooperative game generated by this set function and the firms extract total industry surplus. If it is concave, the only equilibrium price of a product is its marginal contribution to the consumer's total willingness to pay. Journal of Economic Lit…

OligopolyMicroeconomicsConsumption (economics)Competition (economics)Economics and EconometricsCore (game theory)StrategyWillingness to paySet functionEconomicsEconomic surplusJournal of Economic Theory
researchProduct

Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid…

2011

a b s t r a c t The function of the natural modulators of BCR-ABL-induced signaling pathways could influence the results to imatinib treatment. We assessed the association between single nucleotide polymorphisms (SNPs) on genes of the phosphatase family and the suppressors of cytokine signaling and the response to imatinib in 105 patients newly diagnosed with chronic-phase CML. SNPs in SOCS1 (rs243327) and PTPN22 (rs2476601) genes correlated with the risk of primary resistance to imatinib. A high-risk Sokal score, the T allele in PTPN22 SNP, and each copy of the C allele in SOCS1 SNP were adverse prognostic factors for failure-free survival (FFS). Based on such parameters, three risk groups…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyAdolescentGenotypeSingle-nucleotide polymorphismAntineoplastic AgentsSuppressor of Cytokine Signaling ProteinsBiologyReal-Time Polymerase Chain ReactionPolymorphism Single NucleotidePiperazinesPTPN22Young AdultSuppressor of Cytokine Signaling 1 Proteinhemic and lymphatic diseasesInternal medicineGenotypemedicineSNPHumansAlleleAgedSuppressor of cytokine signaling 1ImatinibProtein Tyrosine Phosphatase Non-Receptor Type 22HematologyDNAMiddle AgedPrognosisPyrimidinesOncologyCase-Control StudiesImmunologyBenzamidesLeukemia Myeloid Chronic-PhaseImatinib MesylateFemaleSokal Scoremedicine.drugLeukemia research
researchProduct

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy

2010

Purpose: Knowledge of prognostic factors for advanced non-small-cell lung cancer (NSCLC) patients eligible for second-line treatment is scarce. The aim of this study was to assess the prognostic role of a number of routinely collected clinical variables and to provide a summary index to discriminate patients according to probability of survival.Methods: individual data from nine randomised trials of second-line treatment in advanced NSCLC were analysed. Primary end-point was overall survival (OS). Cox model, stratified by trial, was used for multivariate analyses, and a prognostic index was provided and validated according to an internal/external procedure.Results: Out of 1239 patients, 119…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyMultivariate analysisLung NeoplasmsWEEKLY DOCETAXELIRINOTECANCOMBINATION CHEMOTHERAPYAntineoplastic AgentsERLOTINIBPrognostic factorsNSCLCTHERAPYPooled analysisPLUS GEMCITABINEInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansStage (cooking)Lung cancerEVERY 3 WEEKSAgedNeoplasm StagingRandomized Controlled Trials as TopicAged 80 and overPerformance statusProportional hazards modelbusiness.industryAge FactorsCombination chemotherapyPHASE-III TRIALMiddle Agedmedicine.diseasePrognosisTreatment OutcomeOncologyMeta-analysisPrognostic scoreCOMPARING DOCETAXELSecond-line treatmentAdenocarcinomaFemalebusinessEpidemiologic MethodsNon-small-cell lung cancerEuropean Journal of Cancer
researchProduct

Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast canc…

2021

Different immunohistochemical programmed death-ligand 1 (PD-L1) assays and scorings have been reported to yield variable results in triple-negative breast cancer (TNBC). We compared the analytical concordance and reproducibility of four clinically relevant PD-L1 assays assessing immune cell (IC) score, tumor proportion score (TPS), and combined positive score (CPS) in TNBC. Primary TNBC resection specimens (n = 104) were stained for PD-L1 using VENTANA SP142, VENTANA SP263, DAKO 22C3, and DAKO 28–8. PD-L1 expression was scored according to guidelines on virtual whole slide images by four trained readers. The mean PD-L1 positivity at IC-score ≥1% and CPS ≥1 ranged between 53% and 75% with th…

OncologyCPS combined positive scoreTC tumor cellsICI immune checkpoint inhibitorTriple Negative Breast NeoplasmsB7-H1 AntigenMedicineHER2 human epidermal growth factor receptor 2Triple-negative breast cancerRC254-282ICC intraclass correlation coefficientbiologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensGeneral MedicineMSI microsatellite instabilityImmunohistochemistrypCR pathological complete responsePFS progression-free survivalImmunohistochemistryOriginal ArticleIC-ScoreIC immune cellsIHC immunohistochemistryProgrammed deathPD-L1medicine.medical_specialtyConcordanceTNBC triple-negative breast cancerOS overall survivalBreast cancerTriple-negative breast cancerPD-L1Internal medicineTPS tumor proportion scoreBiomarkers TumorHumansProgrammed death-ligand 1Reproducibilitybusiness.industryReproducibility of Resultsmedicine.diseaseITT intention to treatCI confidence intervalPD-L1 programmed death-ligand 1biology.proteinSurgeryCPSbusinessKappaTMB tumor mutational burdenBreast
researchProduct

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

2020

OncologyCancer Researchmedicine.medical_specialtySurvival risk scoreChronic lymphocytic leukemiaTreatment outcomeAntineoplastic Agentsrisk scoreNOchemistry.chemical_compoundrelapsed/refractory chronic lymphocytic leukemiaAntineoplastic Agents ImmunologicalPiperidinesibrutinibInternal medicinemedicineHumansreal-lifeMolecular Targeted TherapyChronicProtein Kinase InhibitorsFramingham Risk ScoreLeukemiachronic lymphocytic leukemia; risk score; prognosisbusiness.industryAdenineB-CellHematologymedicine.diseasePrognosisLeukemia Lymphocytic Chronic B-Cellprognostic scoreLymphocyticSurvival risk score real-life relapsed/refractory chronic lymphocytic leukemia ibrutinibLeukemiaSettore MED/15 - MALATTIE DEL SANGUEImmunologicalTreatment OutcomeOncologychemistryIbrutinibRelapsed refractorychronic lymphocytic leukemiabusiness
researchProduct

Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancer

2011

Objectives:  Accurate tumor grading on prostate biopsy represents the mainstay for therapy planning. Biopsy undergrading is a persistent diagnostic dilemma with therapeutic relevance. We questioned whether Gleason grading combined with an established alternative grading system incorporating cytological parameters improves grading accuracy. Methods:  Needle biopsies of 968 patients and the corresponding radical prostatectomy specimens were graded according to the Gleason grading system. In addition, all biopsies were graded according to the histo- and cytological grading system of Helpap. Biopsy Gleason grade, as well as the combined Gleason/Helpap grade, was compared with the final Gleason …

OncologyGleason grading systemmedicine.medical_specialtyNeoplasm GradingProstate biopsymedicine.diagnostic_testProstatectomybusiness.industryUrologymedicine.medical_treatmenturologic and male genital diseasesmedicine.diseaseGleason Score 6Prostate cancerInternal medicineBiopsymedicineRadiologyGrading (education)businessneoplasmsInternational Journal of Urology
researchProduct